Table 4.
L-LMICS | UM-HICs | Total | p-Value between the Groups of Countries | |
---|---|---|---|---|
Total | 66.6% (511/767) | 78.5% (596/759) | 72.5% (1107/1526) | <0.001 ** |
Age | ||||
18–29 years | 68% (410/603) | 77.6% (396/510) | 72.4% (806/1113) | <0.001 ** |
30–49 years | 62.5% (90/144) | 78.8% (182/231) | 72.5% (272/375) | 0.001 ** |
≥ 50 years | 55% (11/20) | 100% (18/18) | 76.3% (29/38) | 0.001 ** |
Sex | ||||
Male | 66% (103/156) | 76.3% (244/320) | 72.9% (347/476) | 0.02 ** |
Female | 66.8% (408/611) | 80.2% (352/439) | 72.4% (760/1050) | <0.001 ** |
Profession | ||||
Dentist | 64.4% (248/385) | 82.8% (384/464) | 74.4% (632/849) | <0.001 ** |
Dental student | 68.8% (263/382) | 71.9% (212/295) ** | 70.2% (475/677) | 0.4 |
Comorbidity | ||||
No | 67.6% (478/707) | 78.9% (539/683) | 73.2% (1017/1390) | <0.001 ** |
Yes | 55% (33/60) ** | 75% (57/76) | 66.2% (90/136) | 0.014 ** |
Previous COVID-19 infection | ||||
No | 67.1% (443/660) | 78.7% (518/658) | 72.9% (961/1318) | <0.001 ** |
Yes | 63.6% (68/107) | 77.2% (78/101) | 70.2% (146/208) | 0.03 ** |
Updating self on the development of COVID-19 vaccines | ||||
No | 49% (77/157) | 62% (93/150) | 55.4% (170/307) | 0.02 ** |
Yes | 71.1% (434/610) ** | 82.6% (503/609) ** | 76.9% (937/1219) ** | <0.001 ** |
Opinion about COVID-19 severity | ||||
Mild | 64.7% (11/17) | 42.9% (9/21) | 52.6% (20/38) | 0.18 |
Moderate | 61.7% (192/311) | 68.7% (184/268) | 64.9% (376/579) | 0.08 |
Severs | 70.2% (308/439) * | 85.7% (403/470) * | 78.2% (711/909) * | <0.001 ** |
Compliance with COVID-19 preventive guidelines | ||||
Good | 68% (230/338) | 81.3% (425/523) | 76.1% (655/861) | <0.001 ** |
Moderate | 66.3% (266/401) | 71.7% (152/212) | 68.2% (418/613) | 0.18 |
Poor | 53.6% (15/28) | 78.3% (18/23) * | 64.7% (33/51) * | 0.07 |
Anxiety about contracting COVID-19 | ||||
Low | 56.8% (46/81) | 64.1% (84/131) | 61.3% (130/212) | 0.29 |
Moderate | 64.5% (284/440) | 76.9% (269/350) | 70% (553/790) | <0.001 ** |
High | 73.6% (181/246) * | 87.4% (243/278) * | 80.9% (424/524) * | <0.001 ** |
Concerned about the side effects of the vaccines | ||||
No | 80.2% (291/363) | 86.3% (378/438) | 83.5% (669/801) | 0.02 ** |
Yes | 54.5% (220/404) ** | 67.9% (218/321) ** | 60.4% (438/725) ** | <0.001 ** |
All comparisons were conducted between different levels of predictors at each cell*: p < 0.05 based on chi-square test for trend. **: p < 0.05 based on chi-square test.